Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma (Q36474467)

14 August 2017

Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma (English)

1 reference

14 August 2017

hepatocellular carcinoma

1 reference

10

Giacomo Zanus

1 reference

14 August 2017

Davide Francesco D'Amico

13

object named as

Davide Francesco D'Amico

1 reference

14 August 2017

Umberto Cillo

1

1 reference

14 August 2017

Alessandro Vitale

2

1 reference

14 August 2017

Filippo Navaglia

3

1 reference

14 August 2017

Daniela Basso

4

1 reference

14 August 2017

Umberto Montin

5

1 reference

14 August 2017

Marco Bassanello

6

1 reference

14 August 2017

Francesco D'Amico

7

1 reference

14 August 2017

Francesco Antonio Ciarleglio

8

1 reference

14 August 2017

Alberto Brolese

9

1 reference

14 August 2017

Vito De Pascale

11

1 reference

14 August 2017

Mario Plebani

12

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

World Journal of Gastroenterology

14 August 2017

1 reference

14 August 2017

11

1 reference

14 August 2017

44

1 reference

14 August 2017

6920-6925

1 reference

Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

The prognostic molecular markers in hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Hepatocellular carcinoma: diagnosis and treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Is surgery for large hepatocellular carcinoma justified?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Prognosis of hepatocellular carcinoma: the BCLC staging classification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Transection of the oesophagus for bleeding oesophageal varices

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717031

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

21 September 2018

1 reference

12 December 2020

Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma

1 reference

12 December 2020

Simplified staging for hepatocellular carcinoma

1 reference

12 December 2020

Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver

1 reference

12 December 2020

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery

1 reference

12 December 2020

Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma

1 reference

12 December 2020

Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma

1 reference

12 December 2020

Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification

1 reference

12 December 2020

Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation

1 reference

12 December 2020

Multimodal approach and its impact on survival for patients with hepatocellular carcinoma

1 reference

12 December 2020

Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I44.6920

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

16437593

1 reference